09/25/2024 5:29 PM | Godwin Mary E. (Reporting) Nautilus Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/23/2024 3:58 PM | Godwin Mary E. (Reporting) Nautilus Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024 5:32 PM | Godwin Mary E. (Reporting) Nautilus Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 3:40 PM | Nautilus Biotechnology (Issuer) Suzuki Kentaro (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/17/2024 3:47 PM | Nautilus Biotechnology (Issuer) Suzuki Kentaro (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 3:22 PM | Godwin Mary E. (Reporting) Nautilus Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024 5:02 PM | EDELMAN JOSEPH (Reporting) Nautilus Biotechnology (Issuer) PERCEPTIVE ADVISORS LLC (Reporting) PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
06/17/2024 5:03 PM | ALTMAN MICHAEL SETH (Reporting) Nautilus Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 5:09 PM | McIlwain Matthew S (Reporting) Nautilus Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 4:37 PM | Epperly Melissa B, (Reporting) Nautilus Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 4:40 PM | Akinsanya Karen (Reporting) Nautilus Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 4:24 PM | Nautilus Biotechnology (Issuer) NAZEM FARZAD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 4:35 PM | Nautilus Biotechnology (Issuer) Pande Vijay Satyanand (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/26/2024 3:12 PM | Nautilus Biotechnology (Filer)
| Form ARS | |
03/11/2024 7:21 PM | Nautilus Biotechnology (Issuer) Patel Sujal M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 6:06 PM | Nautilus Biotechnology (Issuer) Patel Sujal M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 11:15 PM | Nautilus Biotechnology (Filer)
| Form EFFECT | |
03/05/2024 3:52 PM | Nautilus Biotechnology (Issuer) Patel Sujal M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 3:42 PM | Mowry Anna (Reporting) Nautilus Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 6:25 AM | Nautilus Biotechnology (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
02/28/2024 6:26 AM | Nautilus Biotechnology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 6:15 AM | Nautilus Biotechnology (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2024 6:03 AM | Nautilus Biotechnology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 6:04 AM | Nautilus Biotechnology (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
12/14/2023 3:17 PM | Nautilus Biotechnology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/16/2023 8:18 PM | Nautilus Biotechnology (Subject) PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |